| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |